2,4-disubstituted pyrimidines useful as kinase inhibitors
申请人:Celgene CAR LLC
公开号:US10010548B2
公开(公告)日:2018-07-03
The present invention provides 2,4-disubstituted pyrimidine compounds useful as kinase inhibitors, pharmaceutically acceptable compositions thereof, and methods of using the same.